Bill Gunderson

About the Author Bill Gunderson

Bill Gunderson is the CEO and Chief Market Strategist of Gunderson Capital Managment in San Diego, CA. He is also a professional money manager, former research analyst, author of Best Stocks Now, and developer of the Best Stocks Now smartphone app. He offers four free weeks to his weekly Best Stocks Now to Seeking Alpha readers. http://www.pwstreet.comHe also hosts a daily stock market radio show on AM1000 KCEO from 7am-8am. http://www.kceoradio.com Bill has appeared on the Fox Business Channel and on Bloomberg radio numerous times.He has been published in Barron's, Forbes, TheStreet.com and numerous other publications i.e. Los Angeles Business Journal, San Diego Union Tribune, Phoenix Business Journal, Salem News, Rochester Business Journal, and many others.

American International Group Inc (AIG), HD Supply Holdings Inc (HDS): Top 5 Stock Picks For 2017

Summary A lot of uncertainty has now been taken out of the market. We are now in a rising interest rate environment.

AutoZone, Inc. (AZO): One of the Great Stocks of the Decade

Now that it looks like the FED will not be raising interest rates anytime soon, the market is all of a sudden back …

TJX Companies Inc (TJX): Still Executing To The Max

Discount clothing and home goods retailer TJX Companies Inc (NYSE:TJX) reported strong results last week, convincingly beating analyst estimates and guiding up both …

The Good, The Bad and The Ugly: Amazon.com, Inc. (AMZN), Apple Inc. (AAPL), Biogen Inc (BIIB)

We are fully into earnings season, and the battle continues. Last week, we had a number of big names report: some good, some …

Hasbro, Inc. (HAS): An Underappreciated Growth Story

Hasbro, Inc. (NASDAQ:HAS) has been around since 1923 and is a company name that most parents and kids recognize.

Anacor Pharmaceuticals Inc (ANAC) May Have A “Home Run” Drug On Its Hands

Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) are soaring thanks to some positive results in two late-stage (Phase 3) trials for a topical ointment …

Seattle Genetics, Inc. (SGEN)’s Collaborative Approach To Fighting Cancer Makes It A Buy

Seattle Genetics, Inc. (NASDAQ:SGEN) is a biotechnology company involved in developing antibody-based therapies for the treatment of cancer.

Valeant Pharmaceuticals Intl Inc: Not Your Average Pharma Stock

  Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription products. The company was …

Actavis plc (ACT): A Leader In ‘Growth Pharma’

  Dublin-based generic and specialty drug company Actavis plc (NYSE:ACT) is a pharma deal-maker. Much of Actavis’ growth as a company has been …

Hasbro, Inc.: Not Just A Toy Story (HAS)

Rhode Island-based Hasbro, Inc. (NASDAQ:HAS) has been around since 1923, and is a company name that most parents and their kids recognize.